期刊文献+

小剂量辛伐他汀对稳定期慢性阻塞性肺疾病患者生活质量的影响 被引量:4

Effect on Small Doses of Simvastatin on Quality of Life of Patients with Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:观察小剂量辛伐他汀(10 mg/次,每晚1次)为期1年的治疗对中度稳定期慢性阻塞性肺疾病(COPD)患者生活质量的影响。方法:选取符合纳入标准的60例中度稳定期慢性阻塞性肺疾病患者,按照随机数字表法将其分为试验组和对照组各30例,对照组采取常规治疗1年,试验组在常规治疗的基础上加用辛伐他汀10 mg/次,每晚1次,口服1年,记录并比较1年前后两组患者COPD评估测试(CAT)评分。结果:两组患者治疗前CAT评分比较差异无统计学意义(P>0.05),治疗1年后两组CAT评分均明显优于治疗前,且试验组CAT评分明显优于对照组,比较差异均有统计学意义(P<0.05)。结论:小剂量辛伐他汀可以改善COPD患者生活质量,值得在临床上推广。 Objective:To observe the low-dose simvastatin(10 mg/times,once a night) a period of one year of treatment for moderate stable chronic obstructive pulmonary disease(COPD) patients quality of life impact.Method:60 patients with moderate stable chronic obstructive pulmonary disease were randomly divided into the experimental group and the control group,30 cases in each group.The control group was treated with conventional therapy for one year,the experimental group was treated with oral simvastatin 10 mg/times,once a night for 1 year on the basis of conventional therapy.COPD assessment test(CAT) score of the two groups before and after one year were recorded and compared.Result:Before treatment,the CAT scores had no significant differences between the two groups(P〉0.05),after one year of treatment,CAT scores of the two groups were significantly better than before treatment,and CAT of the experimental group was significantly better than the control group,the differences were statistically significant(P〈0.05).Conclusion:Low-dose simvastatin can improve the quality of life in patients with COPD,it is worth promoting in clinical practice.
出处 《中国医学创新》 CAS 2014年第6期40-41,共2页 Medical Innovation of China
基金 2012年深圳市宝安区科学技术局立项(2012019)
关键词 慢性阻塞性肺疾病 辛伐他汀 Chronic obstructive pulmonary disease Simvastatin
  • 相关文献

参考文献6

二级参考文献68

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2何智辉,陈平.慢性阻塞性肺疾病患者体内白介素-6和C反应蛋白质量浓度的变化及意义[J].中国实用内科杂志,2006,26(7):989-991. 被引量:50
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8240
  • 4Sφyseth V,Brekke PH,Smith P,et al.Statin use is associated with reduced mortality in COPD[J].Eur Respir J,2007,29(2):279-283.
  • 5Lee JH,Lee DS,Kim EK,et al.Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs[J].Am J Respir Crit Care Med,2005,172(8):987-993.
  • 6Hurst JR,Perera WR,Wilkinson TM,et al.Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease[J].Am J Respir Grit Care Med,2006,173 (1):71-78.
  • 7Walter RE,Wilk JB,Larson MG,et al.Systemic inflammation and COPD:the Framingham Heart Study[J].Chest,2008,133 (1):19-25.
  • 8Xing XQ,Gan Y,Wu SJ,et al.Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway[J].Med Hypotheses,2007,68 (5):1108-1113.
  • 9Kim JS,Rubin BK.Nasal and sinus involvement in chronic obstructive pulmonary disease[J].Curt Opin Pulm Med,2008,14 (2):101-104.
  • 10Pauwels RA,Buist AS,Calverley PM,et al. Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease:NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD)workshop summary. Am J Respir Crit Care Med,2001,163:1256-1276.

共引文献8268

同被引文献48

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部